TRV GP’s Rhythm Pharmaceuticals RYTM Stock Holding History

TRV GP’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,781,437	Closed	-$38.5M	–	3
2019 Q3	$38.5M	Sell	1,781,437 -200,000	-10%	-$4.29M	60.35%	1
2019 Q2	$43.6M	Hold	1,981,437	–	–	49.33%	1
2019 Q1	$54.3M	Sell	1,981,437 -1,000,000	-34%	-$28.7M	53.78%	1
2018 Q4	$80.1M	Hold	2,981,437	–	–	79.96%	1
2018 Q3	$87M	Sell	2,981,437 -1,000,000	-25%	-$31.6M	72.32%	1
2018 Q2	$124M	Hold	3,981,437	–	–	78.39%	1
2018 Q1	$79.2M	Hold	3,981,437	–	–	56.15%	1
2017 Q4	$116M	Buy	+3,981,437	New	+$105M	52.29%	1

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

TRV GP's RYTM Position: Q4 2019 in Review

TRV GP sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2019, closing a stake of 1,781,437 shares — an estimated $38.5M sold.

TRV GP first reported a position in RYTM in Q4 2017 and held it in 8 quarters. The position peaked at $124M in Q2 2018. 89 funds tracked by Wall St. Rank hold RYTM as of Q4 2019.

TRV GP reported no remaining Rhythm Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
TRV GP sold 1,781,437 Rhythm Pharmaceuticals shares in Q4 2019, an estimated $38.5M.
TRV GP first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 8 quarters.
TRV GP's Rhythm Pharmaceuticals position peaked at $124M in Q2 2018.
89 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2019.

Based on TRV GP's 13F filing for Q4 2019, filed 5 Feb 2020.